Why NBIS Stock Is in the Spotlight

NBIS stock has surged from under $20 to more than $115 in a few months. Many retail traders see it as the next big AI opportunity. But while the momentum looks impressive, the fundamentals and market signals tell a very different story.

Valuation Metrics Are Alarming

The current valuation of NBIS stock is detached from reality:

  • Market Capitalization: $29 billion
  • Revenue: $241 million
  • Price-to-Sales (P/S): 120
  • Book Value per share: $15.82 vs market price above $115

This means investors are paying 120 times annual sales for a company still struggling with profitability. Historically, such extremes are unsustainable.

EPS vs Net Income: A Red Flag

While reported net income is $240 million, earnings per share (EPS) are negative:

  • EPS (ttm): –1.03
  • Forward EPS: –2.23

This suggests that the apparent profit may include one-time gains, while core operations remain unprofitable. For shareholders, EPS is the key measure, and it clearly shows losses.

Options Market Sentiment: Institutions Are Bearish

Option order flow gives additional warning signs:

  • September 22, 2025: net option delta –153K (bearish)
  • October 1, 2025: slight recovery to +52K, but institutions stayed net short
  • Retail traders continue buying calls, while professionals and institutions are on the sell side

This divergence is a classic signal: retail is buying the hype, institutions are unloading.

Technical Analysis: Parabolic and Overbought

The chart of NBIS stock shows:

  • Over +300% performance year-to-date
  • RSI near 74, indicating overbought conditions
  • Resistance in the $115–118 range, with support closer to $100

Parabolic price moves rarely last. A retracement toward $90–100 is highly possible.

Why NBIS Stock Is a Dangerous Buy

  1. Extremely high valuation: P/S 120
  2. Negative EPS despite reported income
  3. Institutions selling into retail demand
  4. Overextended technical setup

Final Verdict: Don’t Buy NBIS Stock

NBIS stock is a textbook case of hype-driven overvaluation. While momentum could briefly push it higher, the downside risk outweighs the upside potential. Disciplined investors should avoid entering at these levels.

The message is clear: don’t buy NBIS stock.

Leave a Reply

Your email address will not be published. Required fields are marked *